SeaBeLife has secured €2.9 million in French government funding to [...]

Gesynta Pharma has completed recruitment for its Phase 2 trial [...]

AltruBio has reported Phase 2a results for ALTB-268 in patients [...]

Johnson & Johnson has reported three-year clinical remission data for [...]

NICE has recommended maralixibat for cholestatic pruritus caused by Alagille [...]

Mursla Bio has published peer-reviewed data showing that isolating liver-derived [...]

MimiVax’s SurVaxM cancer vaccine improved overall survival in a Phase [...]

UK biotech Myomaker Bio has developed lab-grown human neuromuscular junctions [...]

BridgeBio has secured FDA Priority Review for its oral infigratinib [...]

ViiV Healthcare’s long-acting HIV treatment Cabenuva achieved superior viral suppression [...]